Barbara Upmeier
25Patents
5h-index
40Co-inventors
69Inventor score
Filing activity: Aug 7, 1995 → Sep 23, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6998246B2 | Method for immobilizing conjugates in diagnostic tests | Emerging Cross-Sectional Technologies | 23 | Expired |
| US5958783A | Metal complexes with a charged linker | Chemistry; Metallurgy | 20 | Expired |
| US6593079B1 | Method for simultaneous detection of HIV antigens and HIV antibodies | Chemistry; Metallurgy | 13 | Expired |
| US6306579A | Recombinant antigen from the NS3 region of the hepatitis C virus | Emerging Cross-Sectional Technologies | 11 | Expired |
| US6096319A | Recombinant antigen from the NS3 region of the hepatitis C virus | Emerging Cross-Sectional Technologies | 10 | Expired |
| US10101349B2 | Analytical test management system and method | Emerging Cross-Sectional Technologies | 5 | Active |
| US11156610B2 | Methods for reducing interferences | Physics | 2 | Active |
| US7604935B2 | Soluble rubella E1 envelope protein variants | Emerging Cross-Sectional Technologies | 2 | Active |
| US7122302B2 | Method for determining early HCV seroconversion | Emerging Cross-Sectional Technologies | 1 | Expired |
| US9267953B2 | Method for detection of specific immunoglobulin class G antibodies | Physics | 1 | Active |
| US6270960A | Recombinant antigen from the NS3 region of the hepatitis C virus | Emerging Cross-Sectional Technologies | 1 | Expired |
| US11099180B2 | Immunoassay using at least two pegylated analyte-specific binding agents | Physics | 0 | Active |
| US11320423B2 | Method for reduction of interferences in immunoassays | Physics | 0 | Active |
| US7351799B2 | Use of intramolecularly, covalently cross-linked proteins as binding partners in immunoassays | Physics | 0 | Expired |
| US11078241B2 | Multi-epitope fusion protein of an HCV antigen and uses thereof | Physics | 0 | Active |
| US10094828B2 | Antigen composition for detecting Chagas disease | Physics | 0 | Active |
| US11150247B2 | Method for serological detection of viral antigens | Physics | 0 | Active |
| US7547533B2 | Use of intramolecularly, covalently cross-linked proteins as binding partners in immunoassays | Physics | 0 | Active |
| US8551696B2 | Rubella E1 envelope protein variants and their use in detection of anti-rubella antibodies | Emerging Cross-Sectional Technologies | 0 | Active |
| US12399176B2 | Methods for reducing interferences | Physics | 0 | Active |
| US10228370B2 | Recombinant Trypanosoma cruzi JL7 antigen variants and their use for detecting Chagas disease | Emerging Cross-Sectional Technologies | 0 | Active |
| US9081016B2 | Assay for measurement of antibodies binding to a therapeutic monoclonal antibody | Physics | 0 | Active |
| US11385250B2 | Systems and methods for classifying a biological sample regarding the presence of an analyte | Physics | 0 | Active |
| US12411129B2 | Reduction of interferences in immunoassays | Physics | 0 | Active |
| US11327077B2 | Pretreatment method for rapid detection of HCV core antigen | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.